Literature DB >> 11915042

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.

Takeya Tsutsumi1, Tetsuro Suzuki, Takashi Shimoike, Ryosuke Suzuki, Kyoji Moriya, Yoshizumi Shintani, Hajime Fujie, Yoshiharu Matsuura, Kazuhiko Koike, Tatsuo Miyamura.   

Abstract

Hepatic steatosis and hepatocellular carcinoma (HCC) are common and serious features of hepatitis C virus (HCV) infection, and the core protein has been shown to play distinct roles in the pathogenesis. Here we report the direct interaction of HCV core protein with retinoid X receptor alpha (RXRalpha), a transcriptional regulator that controls many aspects of cell proliferation, differentiation, and lipid metabolism. The core protein binds to the DNA-binding domain of RXRalpha, leading to increase the DNA binding of RXRalpha to its responsive element. In addition, RXRalpha is activated in cells expressing the core protein as well as in the livers of the core-transgenic mice that would develop hepatic steatosis and HCC later in their lives. Using promoter genes of cellular retinol binding protein II (CRBPII) and acyl-CoA oxidase as reporters, we also show that the expression of the core protein enhances the transcriptional activity regulated by the RXRalpha homodimer as well as by the heterodimer with peroxisome proliferator activated receptor alpha. Furthermore, expression of the CRBPII gene is also up-regulated in the livers of HCV core-transgenic mice. In conclusion, these results suggest that modulation of RXRalpha-controlled gene expression via interaction with the core protein contributes to the pathogenesis of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11915042     DOI: 10.1053/jhep.2002.32470

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation.

Authors:  Shinji Kusakabe; Tatsuya Suzuki; Yukari Sugiyama; Saori Haga; Kanako Horike; Makoto Tokunaga; Junki Hirano; He Zhang; David Virya Chen; Hanako Ishiga; Yasumasa Komoda; Chikako Ono; Takasuke Fukuhara; Masahiro Yamamoto; Masahito Ikawa; Takashi Satoh; Shizuo Akira; Tomohisa Tanaka; Kohji Moriishi; Moto Fukai; Akinobu Taketomi; Sachiyo Yoshio; Tatsuya Kanto; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.

Authors:  Junki Hirano; Toru Okamoto; Yukari Sugiyama; Tatsuya Suzuki; Shinji Kusakabe; Makoto Tokunaga; Takasuke Fukuhara; Miwa Sasai; Takahiro Tougan; Yasue Matsunaga; Kazuo Yamashita; Yusuke Sakai; Masahiro Yamamoto; Toshihiro Horii; Daron M Standley; Kohji Moriishi; Kyoji Moriya; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

3.  Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.

Authors:  Eun Kim; Ke Li; Charmiane Lieu; Shuping Tong; Shigenobu Kawai; Takayoshi Fukutomi; Yonghong Zhou; Jack Wands; Jisu Li
Journal:  J Hepatol       Date:  2008-09-07       Impact factor: 25.083

Review 4.  The interaction between HCV and nuclear receptor-mediated pathways.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Yvonne Wan
Journal:  Pharmacol Ther       Date:  2011-05-18       Impact factor: 12.310

Review 5.  Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection.

Authors:  Nathan L Meyers; Krystal A Fontaine; G Renuka Kumar; Melanie Ott
Journal:  Curr Opin Cell Biol       Date:  2016-05-27       Impact factor: 8.382

6.  Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.

Authors:  Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus.

Authors:  Kohichiroh Yasui; Yuichi Harano; Hironori Mitsuyoshi; Kazuhiro Tsuji; Mio Endo; Tomoaki Nakajima; Masahito Minami; Yoshito Itoh; Yoh Zen; Yasuni Nakanuma; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

9.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

Review 10.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.